Daiichi Sankyo

Daiichi Sankyo is one of the...

• Forbes Global 2000 (#807);
• Nikkei 225;
• Topix.

Daiichi Sankyo is a company listed under the stock ticker 4568 (JP).

Daiichi Sankyo has a direct presence in 11 countries.

Daiichi Sankyo has 12 subsidiaries including American Regent, ASCA and Daiichi Sankyo Benelux.

They are in:

• Pharmaceuticals92%
• Healthcare8%

View the org chart displaying its 107 main executives

Most searched biographies at Daiichi Sankyo

• Sunao Manabe, Executive President, President, Chief Executive Offi...
• Yasuhiro Komatsu, Outside Director
• Masako Watanabe, Supervisory Board Member

Create your alert
to follow the executive moves at Daiichi Sankyo.

Daiichi Sankyo has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Daiichi Sankyo

Social media about Daiichi Sankyo

• Daiichi Sankyo on Wikipedia, Google News & Yahoo Finance
• Daiichi Sankyo on LinkedIn, Twitter & YouTube

Contact by email its executives including Sunao Manabe

Call Daiichi Sankyo at +81 36...

View the org chart

Register to receive your alert

Report an error